导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -16.78% | 948/1050 |
| 近一周 | -3.19% | 833/1104 |
| 近一月 | -5.13% | 619/1102 |
| 近一季 | -2.43% | 345/1092 |
| 近半年 | -10.84% | 792/1070 |
| 近一年 | -25.06% | 961/1018 |
| 近两年 | 17.58% | 794/926 |
| 近三年 | 2.72% | 647/834 |
| 成立以来 | -10.61% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-11.63% 1027/1070 |
-6.67% 838/1101 |
- - |
- - |
| 2025 | 24.00% 601/1065 |
14.59% 57/1014 |
6.05% 235/1038 |
16.73% 706/1050 |
-12.59% 944/1065 |
| 2024 | 15.76% 152/1011 |
-1.53% 402/960 |
5.53% 80/983 |
15.48% 203/991 |
-3.53% 574/1011 |
| 2023 | -24.05% 760/952 |
-6.16% 821/880 |
-8.41% 708/895 |
-1.26% 126/915 |
-10.50% 874/952 |
| 2022 | -27.21% 557/867 |
-20.90% 568/773 |
6.91% 414/806 |
-25.48% 801/845 |
15.51% 36/867 |
| 2021 | -7.69% 457/740 |
-4.21% 312/580 |
13.65% 268/659 |
-7.22% 425/704 |
-8.61% 646/740 |
| 2020 | 25.59% 366/554 |
-10.97% 390/419 |
19.39% 295/466 |
5.04% 364/517 |
12.49% 270/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 工银沪港深股票C VS. 东吴新产业精选股票A(580008) |